An autoimmune inflammatory disorder, Rheumatoid arthritis (RA), develops when the body’s immune system attacks healthy cells, resulting in inflammation. RA mainly affects the joints, usually more than one joint simultaneously. As a shock absorber for joints, RA damages the cartilage by uncontrolled inflammation. The result is deformed joints over time. Finally, the bone itself starts … Continued
Safe and effective use of health products is a key objective of pharmacovigilance. Information is provided about the safety of these substances to patients, healthcare providers, and the general public as soon as possible. Pharmacovigilance includes reviewing the development, management, and introduction of pharmaceuticals. It is probably the most tightly regulated part of the pharmaceutical … Continued
The development of a generic drug is very different from that of an innovative drug with a novel chemical composition. It must be sufficiently comparable to the latter to determine whether a generic drug is therapeutically equivalent to an innovator product. To be market-effective, drug companies must develop generic drugs that achieve the same level … Continued
ClinChoice strives to set the Standard of Excellence, but such ambition is not achieved alone. The largest contributors to ClinChoice’s success are the people that help support the company’s mission. Watch now and take a look at why ClinChoice’s longstanding employees value the company just as much as ClinChoice values them.
After many months of planning and anticipation, DIA 2022 in Chicago finally arrived. For the first time in over 2 years, colleagues, partners, and friends gathered at the Drug Information Association conference in person. And then, seemingly in the blink of an eye, the conference was over! Here are some key takeaways from ClinChoice: Technology: … Continued
Clinical research is a rapidly evolving field. As technologies improve and advanced capabilities become accessible, new tools, methodologies, and processes also emerge. Depending on the area of research, size, target demographics, and other factors, these new technologies can help improve efficiency, accuracy, speed, and the quality of data gathered and analyzed. A key element of … Continued
How rare are rare diseases? The Orphan Drug Act defines a rare disease as a disease or condition that affects less than 200,000 people in the United States.
We have a diverse client base who develop lifechanging medical devices, vaccines, and other products. Our enriching work environment offers programmers exposure to a wide range of clients, scientific areas, geographic settings, and a highly talented, multicultural team. Watch now to learn more about our industry-leading team, exceptional leadership, remote or hybrid work model, and … Continued
With the backing of exciting new investors, ClinChoice is charting a new course that combines our expertise and ambition to aid the continuous development and monitoring of new drugs, devices, and vaccines. Listen to Mahesh Mudnur – President, Asia-Pacific, and Sridhar Punniamurthi – Director, Statistical Programming, as they share their vision for the Biometrics group in 2022.
This past week, ClinChoice participated in the Outsourcing Clinical Trials conference in Boston as a Sponsor.
